secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caris Life Sciences, Inc. (CAI)
CIK:        0002019410
Form:       8-K
Filed at:   2026-06-05T21:03:34+00:00
Accession:  0002019410-26-000046
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Caris Life Sciences shareholders elect ten directors, ratify Deloitte as auditor for FY2026
--------------------------------------------------------------------------------

- Annual Meeting held June 4, 2026; 273.7M shares represented (96.8% of 282.7M outstanding).
- All ten director nominees elected with votes ranging from 200.4M to 228.7M in favor.
- Deloitte & Touche LLP ratified as independent auditor: 273.5M for, 60.9K against, 136.3K abstentions.
- Broker non-votes of 11.1M recorded on director election but not on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2019410/000201941026000046/0002019410-26-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2019410/000201941026000046/cai-20260604.htm
  HTML page:      https://secwatch.observer/filing/0002019410-26-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer